Pricing Log in Create free account

Neumora Therapeutics, Inc. (NMRA) vs Promis Neurosciences (PMN)

Neumora Therapeutics, Inc. and Promis Neurosciences are both Biotechnology companies. Neumora Therapeutics, Inc. and Promis Neurosciences are of similar size ($80.2M and $78.0M). Across the 9 metrics below, Promis Neurosciences leads on 7 and Neumora Therapeutics, Inc. on 2.

Valuation

Metric NMRA PMN Biotechnology median
P/E n/m n/m 8.50
P/S n/m 33,868.44 9.71
P/B 1.95 1.51 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales n/m 11,382.03 9.21
Earnings yield (261.70%) (155.70%) (33.15%)
Free cash flow yield (207.20%) (56.51%) (25.50%)

Profitability

Metric NMRA PMN Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (187.11%) (172.30%) (56.36%)
Return on assets (121.89%) (127.57%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric NMRA PMN Biotechnology median
Revenue growth (TTM) — 450.00% 6.02%
EPS growth (last fiscal year) 5.23% (922.18%) 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric NMRA PMN Biotechnology median
Debt to equity 1.19 0.00 0.00
Current ratio 4.50 7.85 4.72
Net debt to EBITDA 0.53 0.15 0.96

Dividend

Metric NMRA PMN Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric NMRA PMN Biotechnology median
Market cap 80.23m 78.02m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack